udies are governed by the IDE regulations [21 CFR part 812].
NSR device studies have fewer regulatory controls than SR studies and are governed by the
abbreviated requirements [21 CFR 812.2(b)]. The major differences are in the approval
process and in the record keeping and reporting requirements. The SR/NSR decision is also
important to FDA because the IRB serves, in a sense, as the Agency's surrogate with
respect to review and approval of NSR studies. FDA is usually not apprised of the
existence of 